During the past decade, Hospital Puerta del Mar; Sevicio de Neurologia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Puerta del Mar; Sevicio de Neurologia" are "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Hospital Puerta del Mar; Sevicio de Neurologia" in a lesser frequency.

Most popular intervention types in "Hospital Puerta del Mar; Sevicio de Neurologia" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (5 trials), "Antihistamine" (1 trials), "Fenebrutinib" (1 trials), "Methylprednisolone" (1 trials) and "Placebo matched to fenebrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Puerta del Mar; Sevicio de Neurologia" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Puerta del Mar; Sevicio de Neurologia". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Puerta del Mar; Sevicio de Neurologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Puerta del Mar; Sevicio de Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".